1 Jung, K. W., Won, Y. J., Hong, S., Kong, H. J. & Lee, E. S. Prediction of Cancer Incidence and Mortality in Korea, 2020. Cancer Res. Treat.52, 351-358, doi:10.4143/crt.2020.203 (2020).
2 Organization, W. H. Cancer, <https://www.who.int/health-topics/cancer #tab=tab _1> (2020, August 30).
3 Hochegger, H., Takeda, S. & Hunt, T. Cyclin-dependent kinases and cell-cycle transitions: does one fit all? Nat. Rev. Mol. Cell Biol.9, 910-916, doi:10.1038/nrm2510 (2008).
4 Drugs.com. Paclitaxel Information from Drugs.com, <https://www.drugs.com /mtm/paclitaxel.html> (2020, March 30).
5 Gong, J. F. et al. [Efficacy of albumin-bound paclitaxel in advanced gastric cancer patients]. Beijing Da Xue Xue Bao Yi Xue Ban46, 144-148 (2014).
6 Nakanishi, K. et al. Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701). Int. J. Clin. Oncol.21, 557-565, doi:10.1007/s10147-015-0919-z (2016).
7 Elmore, S. Apoptosis: a review of programmed cell death. Toxicol. Pathol.35, 495-516, doi:10.1080/01926230701320337 (2007).
8 Huisman, C. et al. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460. Clin. Cancer. Res.8, 596-606 (2002).
9 Zhou, H. B. & Zhu, J. R. Paclitaxel induces apoptosis in human gastric carcinoma cells. World J. Gastroenterol.9, 442-445, doi:10.3748/wjg.v9.i3.442 (2003).
10 Yun, C. W. & Lee, S. H. The Roles of Autophagy in Cancer. Int. J. Mol. Sci.19, doi:10.3390/ijms19113466 (2018).
11 Mathew, R., Karantza-Wadsworth, V. & White, E. Role of autophagy in cancer. Nat. Rev. Cancer7, 961-967, doi:10.1038/nrc2254 (2007).
12 Jiang, P. & Mizushima, N. LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells. Methods75, 13-18, doi:10.1016/j.ymeth.2014.11.021 (2015).
13 Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy4, 151-175, doi:10.4161/auto.5338 (2008).
14 Young, A. R. et al. Autophagy mediates the mitotic senescence transition. Genes Dev.23, 798-803, doi:10.1101/gad.519709 (2009).
15 Bordin, D. L. et al. DNA alkylation damage and autophagy induction. Mutat. Res.753, 91-99, doi:10.1016/j.mrrev.2013.07.001 (2013).
16 Gomes, L. R., Menck, C. F. M. & Leandro, G. S. Autophagy Roles in the Modulation of DNA Repair Pathways. Int. J. Mol. Sci.18, doi:10.3390/ijms18112351 (2017).
17 Bhat, P. et al. Modulating autophagy in cancer therapy: Advancements and challenges for cancer cell death sensitization. Biochem. Pharmacol.147, 170-182, doi:10.1016/j.bcp.2017.11.021 (2018).
18 Imreh, G., Norberg, H. V., Imreh, S. & Zhivotovsky, B. Publisher's Note: Chromosomal breaks during mitotic catastrophe trigger gammaH2AX-ATM-p53-mediated apoptosis. J. Cell Sci. doi: 10.1242/jcs.081612. J. Cell Sci.130, 3418, doi:10.1242/jcs.210682 (2017).
19 Brito, D. A. & Rieder, C. L. Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr. Biol.16, 1194-1200, doi:10.1016/j.cub.2006.04.043 (2006).
20 Mc Gee, M. M. Targeting the Mitotic Catastrophe Signaling Pathway in Cancer. Mediators Inflamm.2015, 146282, doi:10.1155/2015/146282 (2015).
21 Jorgensen, P. & Tyers, M. How cells coordinate growth and division. Curr. Biol.14, R1014-1027, doi:10.1016/j.cub.2004.11.027 (2004).
22 Malumbres, M. & Barbacid, M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer9, 153-166, doi:10.1038/nrc2602 (2009).
23 Massague, J. G1 cell-cycle control and cancer. Nature432, 298-306, doi:10.1038/nature03094 (2004).
24 Liu, K. et al. Association and clinicopathologic significance of p38MAPK-ERK-JNK-CDC25C with polyploid giant cancer cell formation. Med. Oncol.37, 6, doi:10.1007/s12032-019-1330-9 (2019).
25 Campisi, J. & d'Adda di Fagagna, F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol.8, 729-740, doi:10.1038/nrm2233 (2007).
26 Beausejour, C. M. et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J.22, 4212-4222, doi:10.1093/emboj/cdg417 (2003).
27 Freund, A., Laberge, R. M., Demaria, M. & Campisi, J. Lamin B1 loss is a senescence-associated biomarker. Mol. Biol. Cell23, 2066-2075, doi:10.1091/mbc.E11-10-0884 (2012).
28 Daar, A. S. Ethical issues--a Middle East perspective. Transplant. Proc.21, 1402-1404 (1989).
29 Jiang, B. H. & Liu, L. Z. Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Drug Resist Updat11, 63-76, doi:10.1016/j.drup.2008.03.001 (2008).
30 Bacus, S. S. et al. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene20, 147-155, doi:10.1038/sj.onc.1204062 (2001).
31 Bressenot, A. et al. Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma. J. Histochem. Cytochem.57, 289-300, doi:10.1369/jhc.2008.952044 (2009).
32 Imamura, Y. et al. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncol. Rep.33, 1837-1843, doi:10.3892/or.2015.3767 (2015).
33 Min, J. et al. Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro. Cell. Physiol. Biochem.48, 1433-1442, doi:10.1159/000492253 (2018).
34 Peng, Z. G. et al. Paclitaxel induces apoptosis in leukemia cells through a JNK activation-dependent pathway. Genet. Mol. Res.15, 15013904, doi:10.4238/gmr.15013904 (2016).
35 Friesen, C., Lubatschofski, A., Glatting, G., Debatin, K. M. & Reske, S. N. Activation of intrinsic apoptotic pathway by Re-188 irradiation and paclitaxel in coronary artery smooth muscle cells. Q. J. Nucl. Med. Mol. Imaging52, 289-295 (2008).
36 Kutuk, O. & Letai, A. Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737. Cancer Res.68, 7985-7994, doi:10.1158/0008-5472.CAN-08-1418 (2008).
37 Obiorah, I., Sengupta, S., Fan, P. & Jordan, V. C. Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death. Br. J. Cancer110, 1488-1496, doi:10.1038/bjc.2014.50 (2014).
38 Wang, Y., Zhou, L., Xiao, M., Sun, Z. L. & Zhang, C. Y. Nanomedicine-based paclitaxel induced apoptotic signaling pathways in A562 leukemia cancer cells. Colloids Surf. B. Biointerfaces149, 16-22, doi:10.1016/j.colsurfb.2016.08.022 (2017).
39 Nimmanapalli, R. et al. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res.61, 759-763 (2001).
40 Shi, Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell9, 459-470, doi:10.1016/s1097-2765(02)00482-3 (2002).
41 Vogelstein, B. & Kinzler, K. W. Cancer genes and the pathways they control. Nat. Med.10, 789-799, doi:10.1038/nm1087 (2004).
42 Wu, Y. T. et al. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J. Biol. Chem.285, 10850-10861, doi:10.1074/jbc.M109.080796 (2010).
43 Lumkwana, D., du Toit, A., Kinnear, C. & Loos, B. Autophagic flux control in neurodegeneration: Progress and precision targeting-Where do we stand? Prog. Neurobiol.153, 64-85, doi:10.1016/j.pneurobio.2017.03.006 (2017).
44 Pankiv, S. et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem.282, 24131-24145, doi:10.1074/jbc.M702824200 (2007).
45 Rubinsztein, D. C., Codogno, P. & Levine, B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov.11, 709-730, doi:10.1038/nrd3802 (2012).
46 Galluzzi, L. et al. Autophagy in malignant transformation and cancer progression. EMBO J.34, 856-880, doi:10.15252/embj.201490784 (2015).
47 Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell132, 27-42, doi:10.1016/j.cell.2007.12.018 (2008).
48 White, E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer12, 401-410, doi:10.1038/nrc3262 (2012).
49 Domenech, E. et al. AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest. Nat. Cell Biol.17, 1304-1316, doi:10.1038/ncb3231 (2015).
50 Jordan, M. A., Toso, R. J., Thrower, D. & Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc. Natl. Acad. Sci. U. S. A.90, 9552-9556, doi:10.1073/pnas.90.20.9552 (1993).
51 Park, J. E. et al. Paclitaxel stimulates chromosomal fusion and instability in cells with dysfunctional telomeres: implication in multinucleation and chemosensitization. Biochem. Biophys. Res. Commun.404, 615-621, doi:10.1016/j.bbrc.2010.12.018 (2011).
52 Trendowski, M., Wong, V., Yu, G. & Fondy, T. P. Enlargement and multinucleation of u937 leukemia and MCF7 breast carcinoma cells by antineoplastic agents to enhance sensitivity to low frequency ultrasound and to DNA-directed anticancer agents. Anticancer Res.35, 65-76 (2015).
53 Wang, X. et al. An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells. PLoS One8, e65686, doi:10.1371/journal.pone.0065686 (2013).
54 Information, N. C. f. B. PubChem Compound Summary for CID 36314, Paclitaxel, <Retrieved December 18, 2020 from https://pubchem.ncbi.nlm.nih.gov /compound/Paclitaxel.> (2020).
55 Blagosklonny, M. V. Cell cycle arrest is not senescence. Aging (Albany N. Y.)3, 94-101, doi:10.18632/aging.100281 (2011).
56 Fridlyanskaya, I., Alekseenko, L. & Nikolsky, N. Senescence as a general cellular response to stress: A mini-review. Exp. Gerontol.72, 124-128, doi:10.1016/j.exger.2015.09.021 (2015).
57 Terzi, M. Y., Izmirli, M. & Gogebakan, B. The cell fate: senescence or quiescence. Mol. Biol. Rep.43, 1213-1220, doi:10.1007/s11033-016-4065-0 (2016).
58 Kavallaris, M. Microtubules and resistance to tubulin-binding agents. Nat. Rev. Cancer10, 194-204, doi:10.1038/nrc2803 (2010).
59 Watanabe, A. et al. BCL2 and BCLxL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells. Exp. Dermatol.22, 518-523, doi:10.1111/exd.12185 (2013).
60 Yasuhira, S., Shibazaki, M., Nishiya, M. & Maesawa, C. Paclitaxel-induced aberrant mitosis and mitotic slippage efficiently lead to proliferative death irrespective of canonical apoptosis and p53. Cell Cycle15, 3268-3277, doi:10.1080/15384101.2016.1242537 (2016).
61 Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods9, 671-675, doi:10.1038/nmeth.2089 (2012).